Blog

2021: A Look Inside Our Crystal Ball (part two)

Posted by Elizabeth Gargill on Tue, Dec 22, 2020

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

2021: A Look Inside Our Crystal Ball (part one)

Posted by Elizabeth Gargill on Mon, Dec 21, 2020

 

As part of our Crystal Ball series, we asked BBK Worldwide President Matt Kibby to share his predictions for 2021, which include engaging  underrepresented populations in clinical research.

Matt Kibby, Principal, President

Is there a particular trend that you expect to have a significant impact on the industry in the coming year?

 

With COVID-19 dominating the headlines for much of 2020, one might expect that a key development for clinical R&D in 2021 will be the continued integration and expansion of services that support the hybridization / decentralization of clinical trials. Keeping trial participants – who tend to be older and at greater risk for complications from COVID-19 – away from clinical trial sites not only reduces the risk of SARS-COV-2 infection, but also offers the possibility of enrichment of the clinical trial experience; reduces the overall visit and expense burden for patients; and, moreover, reduces the trial burden on clinical trial site healthcare professionals.

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Most Viewed, Patient Enrollment, Matt Kibby, Clinical Trial Patient Travel, 2021 Predictions, 2021, Underserved Populations

Jessica Kim Named to PharmaVOICE 100 for Her Leadership and Expertise

Posted by Elizabeth Gargill on Tue, Sep 1, 2020

 

BBK Worldwide is honored to announce that our Creative Director for Patient Experience and Engagement, Jessica Kim, has been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences industry as a patient champion. The award recognizes Ms. Kim for how she inspires and motivates those around her, her influence as a corporate leader, and her positive impact on the industry through her actions.

Read More

Topics: Patient Engagement, Patient Enrollment, Study-life Balance, PharmaVOICE, Jessica Kim, PharmaVOICE 100

Managing Patient Travel as Countries and Study Sites Reopen

Posted by Elizabeth Gargill on Wed, Jul 29, 2020

The Road to Reopening

In our newest Pharma15 Live! episode, Principal of RSG Services Rob Laurens provides guidance on managing clinical trial patient travel as COVID-19 restrictions ease and countries and study sites start to reopen.

Rob answers common questions and highlights the advantages of thoughtful pre-planning and contingency preparation. Watch now and discover strategies clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond.

 

Download the eBook

Download eBook

 

Because there's a lot to consider in terms of managing patient travel as COVID-19 restrictions ease, we've captured guidance in a special eBook to download and review at your convenience.

 

Read More

Topics: Patient Engagement, Patient Travel, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Rob Laurens

How Clinical Trial Sponsors Are Responding to COVID-19

Posted by David Fleishman on Fri, Jul 24, 2020

 

We recently sat down with BBK’s Director of Accounts David Fleishman to discuss his experience working with clinical trial sponsors during the COVID-19 outbreak. It’s clear from our conversation that many clinical trial sponsors have had to quickly pivot in response to COVID-19 and are now facing the challenge of adapting to a new normal.

 

Read More

Topics: Patient Engagement, Patient Enrollment, COVID-19, David Fleishman, Virtual

Listening to the Patient Voice Is More Important Now Than Ever Before

Posted by BBK Worldwide on Tue, Jun 30, 2020

 

As we navigate COVID-19 and beyond, understanding the patient voice is critical to overcoming clinical trial enrollment and engagement challenges. Our Study Voices infographic series sheds light on the patient voice, providing clinical trial sponsors with insight to help enhance the patient experience.

Read More

Topics: Patient Engagement, Patient Enrollment, COVID-19, Patient Voice, Infographics

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

Posted by Elizabeth Gargill on Thu, Apr 23, 2020

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

Minimizing Clinical Trial Disruption from COVID-19

Posted by Elizabeth Gargill on Thu, Apr 2, 2020

BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak. 

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

The Art and Science of Clinical Trial Feasibility

Posted by Alexia Medici, Account Executive on Wed, Feb 12, 2020

 

Determining site feasibility is something that most investigators and site coordinators are familiar with. However, once the questionnaire is filled out and provided back to the sponsor and/or CRO, sites may not be aware of the internal process a reviewing entity may have in evaluating the site’s feasibility for the study. As a former clinical research coordinator, I was curious about this. So, I decided to work with BBK's President Matt Kibby, who has been revolutionizing the site feasibility process for the past 20 years. Together, we worked to understand and provide greater context to current site staff regarding the way BBK views and evaluates sites for study feasibility.

Read More

Topics: Site Selection, Site Engagement, Patient Enrollment, Feasibility

3 Myths That May Be Sabotaging Your Clinical Trial Enrollment Effort

Posted by Elizabeth Gargill on Fri, Jan 24, 2020

 

Myths are stubborn, persistent, and can easily put your well-intentioned clinical trial enrollment efforts at risk. But spotting and correcting them can be a challenge. To help the industry discern fact from fiction, we assembled our own MythBusters team, dedicated to confirming or busting common clinical trial myths. Empowered with data from our industry-wide surveys of patients, physicians, and clinical trial sponsors, the team identifies pervasive myths, puts them to the test, and arrives at a verdict.

Read More

Topics: Patient Engagement, Patient Experience, Study Voices, MythBusters, Patient Enrollment